Rare lephants
Screener

ProQR Therapeutics N.V.

PRQR ·Healthcare, Drug Manufacturers - General
Financial Statements › SEC Filings

SEC Filings

Form Filed Description
6-K May 12, 2026 6-K
6-K May 12, 2026 FORM 6-K
6-K May 4, 2026 FORM 6-K
6-K Apr 30, 2026 FORM 6-K
6-K Apr 8, 2026 FORM 6-K
6-K Apr 8, 2026 FORM 6-K
6-K Mar 25, 2026 FORM 6-K
3 Mar 18, 2026 OWNERSHIP DOCUMENT
3 Mar 18, 2026 OWNERSHIP DOCUMENT
3 Mar 18, 2026 OWNERSHIP DOCUMENT
3 Mar 18, 2026 OWNERSHIP DOCUMENT
3 Mar 18, 2026 OWNERSHIP DOCUMENT
3 Mar 18, 2026 OWNERSHIP DOCUMENT
3 Mar 18, 2026 OWNERSHIP DOCUMENT
3 Mar 18, 2026 OWNERSHIP DOCUMENT
3 Mar 18, 2026 OWNERSHIP DOCUMENT
3 Mar 18, 2026 OWNERSHIP DOCUMENT
20-F Mar 12, 2026 20-F
6-K Mar 12, 2026 FORM 6-K
6-K Feb 9, 2026 FORM 6-K
SCHEDULE 13D/A Feb 6, 2026
SCHEDULE 13G Jan 20, 2026
6-K Jan 8, 2026 FORM 6-K
6-K Nov 6, 2025 6-K
6-K Nov 3, 2025 FORM 6-K
← Newer Page 2 of 16 · 389 filings Older →